Vaxcyte, Inc.
PCVX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$213 | -$167 | -$141 | -$137 |
| Dep. & Amort. | $5 | $5 | $5 | $5 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $35 | $37 | $31 | $24 |
| Change in WC | $14 | $34 | -$50 | -$2 |
| Other Non-Cash | $15 | -$30 | -$12 | -$1 |
| Operating Cash Flow | -$143 | -$121 | -$166 | -$111 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$12 | $20 | -$27 | -$30 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$349 | -$314 | -$815 |
| Inv. Sales/Matur. | $0 | $437 | $465 | $288 |
| Other Inv. Act. | $133 | -$29 | $0 | $0 |
| Investing Cash Flow | $121 | $78 | $123 | -$557 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $3 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$4 | -$1 | $1 | $5 |
| Financing Cash Flow | -$4 | $3 | $1 | $5 |
| Forex Effect | $0 | $1 | $1 | $1 |
| Net Chg. in Cash | -$26 | -$40 | -$41 | -$662 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $308 | $348 | $389 | $1,052 |
| End Cash | $283 | $308 | $348 | $389 |
| Free Cash Flow | -$155 | -$102 | -$193 | -$141 |